EUVIMEDEUVIMED entdecken
Crossref

Prediction of Adverse Obstetric Outcomes in High-Risk Pregnancies Using Maternal Serum PAPP-A, β-hCG and Placental Growth Factor Levels

Srushti Parmar, Tithi Joshi, Parin N. Shah

International Journal of Current Pharmaceutical Review and Research · 28.02.2026 · 18 (02)

DOI: 10.25258/ijcpr.18.2.261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 28.02.2026. Verfasst von Srushti Parmar und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-risk pregnancies are predisposed to adverse outcomes, including preeclampsia, fetal growth restriction, preterm birth, and stillbirth. This study evaluated the predictive utility of first-trimester maternal serum placental growth factor (PlGF), beta-human chorionic gonadotropin (β-hCG), and pregnancy-associated plasma protein-A (PAPP-A) for anticipating complications in women with established obstetric risk factors.

Methods

In this prospective cohort study, 200 high-risk pregnant women (18–40 years, 11–13+6 weeks’ gestation) were recruited from a tertiary maternity center. High-risk status included chronic hypertension, diabetes, prior preeclampsia, or abnormal uterine artery Doppler findings. Serum PlGF, free β-hCG, and PAPPA were measured via automated immunoassays and expressed as MoM adjusted for maternal weight, parity, and ethnicity. Primary endpoints were a composite of preeclampsia, intrauterine growth restriction (

Zitieren

APA

Parmar, S., Joshi, T., & Shah, P. N. (2026). Prediction of Adverse Obstetric Outcomes in High-Risk Pregnancies Using Maternal Serum PAPP-A, β-hCG and Placental Growth Factor Levels. International Journal of Current Pharmaceutical Review and Research, 18(02). https://doi.org/10.25258/ijcpr.18.2.261

Vancouver

Parmar S, Joshi T, Shah PN. Prediction of Adverse Obstetric Outcomes in High-Risk Pregnancies Using Maternal Serum PAPP-A, β-hCG and Placental Growth Factor Levels. International Journal of Current Pharmaceutical Review and Research. 2026;18(02). doi:10.25258/ijcpr.18.2.261

BibTeX
@article{Parmar2026,
  author = {Parmar, Srushti and Joshi, Tithi and Shah, Parin N.},
  title = {Prediction of Adverse Obstetric Outcomes in High-Risk Pregnancies Using Maternal Serum PAPP-A, β-hCG and Placental Growth Factor Levels},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {02},
  doi = {10.25258/ijcpr.18.2.261}
}
Kostenlos starten →